ClinicalTrials.gov
ClinicalTrials.gov Menu

The Utility of FDG-PET for Radiation Treatment in NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00385164
Recruitment Status : Unknown
Verified August 2011 by AHS Cancer Control Alberta.
Recruitment status was:  Recruiting
First Posted : October 6, 2006
Last Update Posted : July 25, 2017
Sponsor:
Collaborator:
Calgary Health Region
Information provided by (Responsible Party):
AHS Cancer Control Alberta

Brief Summary:
Patients planned for radical radiation for NSCLC will undergo conventional CT stimulation and also PET/CT scans for definition of radiation target volumes

Condition or disease Intervention/treatment
Lung Neoplasms Positron Emission Tomography Procedure: PET/CT scan for RT planning

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Utility of 18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for Radiation Treatment Planning in Non-Small Cell Lung Cancer (NSCLC)
Study Start Date : October 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lung Cancer
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Non-small cell lung cancer
Criteria

Inclusion Criteria:

  • Non-small cell lung cancer to receive radical radiation

Exclusion Criteria:

  • unable to tolerate PET/CT scan

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00385164


Contacts
Contact: Harold P Lau, MD 403-521-3012

Locations
Canada, Alberta
Tom Baker Cancer Centre Recruiting
Calgary, Alberta, Canada, T2N 4N2
Contact: Marilyn David    403-521-3619    marilyn.david@albertahealthservices.ca   
Sponsors and Collaborators
AHS Cancer Control Alberta
Calgary Health Region
Investigators
Principal Investigator: Harold P Lau, MD AHS Cancer Control Alberta

Responsible Party: AHS Cancer Control Alberta
ClinicalTrials.gov Identifier: NCT00385164     History of Changes
Other Study ID Numbers: 20328
E-20328
First Posted: October 6, 2006    Key Record Dates
Last Update Posted: July 25, 2017
Last Verified: August 2011

Keywords provided by AHS Cancer Control Alberta:
lung neoplasms
positron emissions tomography
radiotherapy planning

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases